Microbiome Sequencing Market By Technique, By Research, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The microbiome sequencing market size was valued for $859.42 million in 2021 and is estimated to reach $3,417.09 million by 2031, exhibiting a CAGR of 14.8% from 2022 to 2031.

Microbiome sequencing is a technique used for decoding the genetic material of all the bacteria, viruses, fungi, and protists in a sample. In addition, microbial sequencing is essential as microbiome is the key to illuminate the structure and functions of specific microbial communities, which is particularly important because many human diseases are linked to the alternation of human microbiome composition. Sequencing of bacterial genomes has significantly improved understanding of bacterial phylogeny and taxonomy. The microbial sequencing allows the detection of variations within the target genomes and interpretation of genetic material in bacteria, virus, fungi, and protists present in the sample.

The driving factors for microbiome sequencing market are use of microbiome sequencing in early disease diagnosis and utilization of this technology in development of personalized medicines for various diseases. For instance, according to article published in Frontiers in Cellular and Infection Microbiology 2021, understanding of the microbiome in pancreatic cancer patients, as well as its manipulation helps in diagnosis and treatment of pancreatic cancer. Further, new therapeutic approaches, called personalized medicine, have opened a new window in medical science, which drives the growth of market. The association between the microbiome and personalized medicine appears to be one of the most interesting aspects of the subsequent research and has a crucial perspective on the treatment of diseases such as cancer and infectious disease. In addition, rise in use of microbiome sequencing in genomics, proteomics, and metabolomics is anticipated to drive the growth of market.

However, factor such as the lack of skilled persons in the operating system of microbiome sequencing restrains the growth of microbiome sequencing market. In addition, stringent rules, and regulations by the governments for microbiome sequencing, also might hinder the growth of market.

The microbiome sequencing market is segmented into technique, research, end user, and region. By technique, the market is categorized into shotgun sequencing, RNA sequencing, targeted gene sequencing, whole-genome sequencing, and others. On the basis of research, the market is segregated into outsourced and internal. On the basis of end user, the market is classified into pharmaceutical &biotechnology companies and Academic Institutes & Research centers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major Key players that operate in the global microbiome sequencing market are Baseclear BV, Charles River Laboratories International, Inc., Clinical Microbiomics, CosmosID, Microbiome Insights, Molecular Research LP, Novogene Co., Ltd., OraSure Technologies (Diversigen), Resphera Biosciences Llc and Zymo Research Corporation.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the microbiome sequencing market analysis from 2021 to 2031 to identify the prevailing microbiome sequencing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the microbiome sequencing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global microbiome sequencing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Technique

Shotgun sequencing
RNA sequencing
Targeted gene sequencing
Whole genome sequencing
Others

By Research

Outsourced
Internal

By End user

Pharmaceutical and biotechnological companies
Academic institutes and research centers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Microbiome Insights
- Clinical Microbiomics
- Baseclear BV
- CosmosID
- Novogene Co., Ltd.
- Zymo Research Corporation
- Resphera Biosciences, LLC
- OraSure Technologies (Diversigen)
- Molecular Research LP
- Charles River Laboratories International, Inc.

Product Code: A13576

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
- 3.4.1.Drivers
  - 3.4.1.1. Rise in investment in microbiome research
  - 3.4.1.2. Use of microbiome in diagnosis of diseases
  - 3.4.1.3. Increase in collaborations and partnerships for microbiome research
- 3.4.2.Restraints
  - 3.4.2.1. Ethical and legal limitations
- 3.4.3.Opportunities
  - 3.4.3.1. Wide applications of microbiome research
3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: MICROBIOME SEQUENCING MARKET, BY TECHNIQUE

4.1 Overview
- 4.1.1 Market size and forecast
4.2. Shotgun sequencing
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3. RNA sequencing
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
4.4. Targeted gene sequencing
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
4.5. Whole genome sequencing
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market share analysis by country
4.6. Others
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market share analysis by country

CHAPTER 5: MICROBIOME SEQUENCING MARKET, BY RESEARCH

5.1 Overview
- 5.1.1 Market size and forecast
5.2. Outsourced
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3. Internal
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country

CHAPTER 6: MICROBIOME SEQUENCING MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2. Pharmaceutical and biotechnological companies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
6.3. Academic institutes and research centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country

CHAPTER 7: MICROBIOME SEQUENCING MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Technique
- 7.2.3 North America Market size and forecast, by Research
- 7.2.4 North America Market size and forecast, by End user
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Key market trends, growth factors and opportunities
  - 7.2.5.1.2 Market size and forecast, by Technique
  - 7.2.5.1.3 Market size and forecast, by Research
  - 7.2.5.1.4 Market size and forecast, by End user
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Key market trends, growth factors and opportunities
  - 7.2.5.2.2 Market size and forecast, by Technique
  - 7.2.5.2.3 Market size and forecast, by Research
  - 7.2.5.2.4 Market size and forecast, by End user
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Key market trends, growth factors and opportunities
  - 7.2.5.3.2 Market size and forecast, by Technique
  - 7.2.5.3.3 Market size and forecast, by Research
  - 7.2.5.3.4 Market size and forecast, by End user
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Technique
- 7.3.3 Europe Market size and forecast, by Research
- 7.3.4 Europe Market size and forecast, by End user
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Key market trends, growth factors and opportunities
  - 7.3.5.1.2 Market size and forecast, by Technique
  - 7.3.5.1.3 Market size and forecast, by Research
  - 7.3.5.1.4 Market size and forecast, by End user
  - 7.3.5.2 UK
  - 7.3.5.2.1 Key market trends, growth factors and opportunities
  - 7.3.5.2.2 Market size and forecast, by Technique
  - 7.3.5.2.3 Market size and forecast, by Research
  - 7.3.5.2.4 Market size and forecast, by End user
  - 7.3.5.3 France
  - 7.3.5.3.1 Key market trends, growth factors and opportunities
  - 7.3.5.3.2 Market size and forecast, by Technique
  - 7.3.5.3.3 Market size and forecast, by Research
  - 7.3.5.3.4 Market size and forecast, by End user
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Key market trends, growth factors and opportunities
  - 7.3.5.4.2 Market size and forecast, by Technique
  - 7.3.5.4.3 Market size and forecast, by Research
  - 7.3.5.4.4 Market size and forecast, by End user
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Key market trends, growth factors and opportunities
  - 7.3.5.5.2 Market size and forecast, by Technique
  - 7.3.5.5.3 Market size and forecast, by Research
  - 7.3.5.5.4 Market size and forecast, by End user
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Key market trends, growth factors and opportunities
  - 7.3.5.6.2 Market size and forecast, by Technique
  - 7.3.5.6.3 Market size and forecast, by Research
  - 7.3.5.6.4 Market size and forecast, by End user
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Technique
- 7.4.3 Asia-Pacific Market size and forecast, by Research
- 7.4.4 Asia-Pacific Market size and forecast, by End user
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Key market trends, growth factors and opportunities
  - 7.4.5.1.2 Market size and forecast, by Technique
  - 7.4.5.1.3 Market size and forecast, by Research
  - 7.4.5.1.4 Market size and forecast, by End user
  - 7.4.5.2 China
  - 7.4.5.2.1 Key market trends, growth factors and opportunities
  - 7.4.5.2.2 Market size and forecast, by Technique
  - 7.4.5.2.3 Market size and forecast, by Research
  - 7.4.5.2.4 Market size and forecast, by End user
  - 7.4.5.3 India
  - 7.4.5.3.1 Key market trends, growth factors and opportunities
  - 7.4.5.3.2 Market size and forecast, by Technique
  - 7.4.5.3.3 Market size and forecast, by Research
  - 7.4.5.3.4 Market size and forecast, by End user
  - 7.4.5.4 Australia
  - 7.4.5.4.1 Key market trends, growth factors and opportunities
  - 7.4.5.4.2 Market size and forecast, by Technique
  - 7.4.5.4.3 Market size and forecast, by Research
  - 7.4.5.4.4 Market size and forecast, by End user
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Key market trends, growth factors and opportunities
  - 7.4.5.5.2 Market size and forecast, by Technique
  - 7.4.5.5.3 Market size and forecast, by Research
  - 7.4.5.5.4 Market size and forecast, by End user
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Key market trends, growth factors and opportunities
  - 7.4.5.6.2 Market size and forecast, by Technique
  - 7.4.5.6.3 Market size and forecast, by Research
  - 7.4.5.6.4 Market size and forecast, by End user
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Technique
- 7.5.3 LAMEA Market size and forecast, by Research
- 7.5.4 LAMEA Market size and forecast, by End user
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Key market trends, growth factors and opportunities
  - 7.5.5.1.2 Market size and forecast, by Technique
  - 7.5.5.1.3 Market size and forecast, by Research
  - 7.5.5.1.4 Market size and forecast, by End user
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Key market trends, growth factors and opportunities
  - 7.5.5.2.2 Market size and forecast, by Technique
  - 7.5.5.2.3 Market size and forecast, by Research
  - 7.5.5.2.4 Market size and forecast, by End user
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Key market trends, growth factors and opportunities
  - 7.5.5.3.2 Market size and forecast, by Technique
  - 7.5.5.3.3 Market size and forecast, by Research
  - 7.5.5.3.4 Market size and forecast, by End user
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Key market trends, growth factors and opportunities
  - 7.5.5.4.2 Market size and forecast, by Technique
  - 7.5.5.4.3 Market size and forecast, by Research
  - 7.5.5.4.4 Market size and forecast, by End user

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

9.1 Microbiome Insights
- 9.1.1 Company overview
- 9.1.2 Key Executives
- 9.1.3 Company snapshot
- 9.1.4 Operating business segments
- 9.1.5 Product portfolio
- 9.1.6 Business performance
- 9.1.7 Key strategic moves and developments
9.2 Clinical Microbiomics
- 9.2.1 Company overview
- 9.2.2 Key Executives
- 9.2.3 Company snapshot
- 9.2.4 Operating business segments
- 9.2.5 Product portfolio
- 9.2.6 Business performance
- 9.2.7 Key strategic moves and developments
9.3 Baseclear BV
- 9.3.1 Company overview
- 9.3.2 Key Executives
- 9.3.3 Company snapshot
- 9.3.4 Operating business segments
- 9.3.5 Product portfolio
- 9.3.6 Business performance
- 9.3.7 Key strategic moves and developments
9.4 CosmosID
- 9.4.1 Company overview
- 9.4.2 Key Executives
- 9.4.3 Company snapshot
- 9.4.4 Operating business segments
- 9.4.5 Product portfolio
- 9.4.6 Business performance
- 9.4.7 Key strategic moves and developments
9.5 Novogene Co., Ltd.
- 9.5.1 Company overview
- 9.5.2 Key Executives
- 9.5.3 Company snapshot
- 9.5.4 Operating business segments
- 9.5.5 Product portfolio
- 9.5.6 Business performance
- 9.5.7 Key strategic moves and developments
9.6 Zymo Research Corporation
- 9.6.1 Company overview
- 9.6.2 Key Executives
- 9.6.3 Company snapshot
- 9.6.4 Operating business segments
- 9.6.5 Product portfolio
- 9.6.6 Business performance
- 9.6.7 Key strategic moves and developments
9.7 Resphera Biosciences, LLC
- 9.7.1 Company overview
- 9.7.2 Key Executives
- 9.7.3 Company snapshot
- 9.7.4 Operating business segments
- 9.7.5 Product portfolio
- 9.7.6 Business performance
- 9.7.7 Key strategic moves and developments
9.8 OraSure Technologies (Diversigen)
- 9.8.1 Company overview
- 9.8.2 Key Executives
- 9.8.3 Company snapshot
- 9.8.4 Operating business segments
- 9.8.5 Product portfolio
- 9.8.6 Business performance
- 9.8.7 Key strategic moves and developments
9.9 Molecular Research LP
- 9.9.1 Company overview
- 9.9.2 Key Executives
- 9.9.3 Company snapshot
- 9.9.4 Operating business segments
- 9.9.5 Product portfolio
- 9.9.6 Business performance
- 9.9.7 Key strategic moves and developments
9.10 Charles River Laboratories International, Inc.
- 9.10.1 Company overview
- 9.10.2 Key Executives
- 9.10.3 Company snapshot
- 9.10.4 Operating business segments
- 9.10.5 Product portfolio
- 9.10.6 Business performance
- 9.10.7 Key strategic moves and developments